2/18/11 Contest Update
Stocks continued to scale the pyramid of worry this week but small cap biotechs found the bricks slippery.
At Friday’s close, the Nasdaq Biotech Index was up 2.21% YTD (vs. up .87% YTD a week ago) and the Contest median was up .03% YTD (vs. up 1.09% YTD a week ago). The Nasdaq Composite Index was up 6.83% YTD (vs. up 5.90% YTD a week ago).
Reflecting the underperformance of baby biotechs, the portfolios of Contest leaders lost ground. GENE’s portfolio (up 23.60% YTD, but down about 5% for the week) remained in first place followed by RKRW’s portfolio (up 18.33% YTD) and RRGE’s portfolio (up 13.63% YTD).
At Friday's close, 19 of the 38 Contest portfolios were in the black with just 14 of the 38 beating the NBI.
Below is the Top Ten list. Also below are the Top 5 & Bottom 5 Stocks ranked by % Gained and % Lost for the week (foreign stock prices are not converted to US$ in these two tables).
Portfolio adjustments: None.
Have a safe & fun Presidents Day weekend biotechies!
(All corrections, especially adjustments for splits, greatly appreciated.)
2/18/11
Rank Name Profit/Loss
1 GENE 23,597
2 RKRW 18,331
3 RRGE 13,632
4 MCBIO 11,299
5 GEORGIA 10,545
6 JIBAC 10,227
7 TECHPER 4,870
8 TECHNET 4,860
9 IMAN 4,780
10 PGO 4,434
Week's Top 5 Gainers
Symbol 2/11 2/18 % change
TSRX 4.30 5.57 29.53%
CLDA 28.44 33.90 19.20%
NEOP 3.20 3.68 15.00%
ALNY 10.00 11.37 13.70%
NRGX.OB 0.75 0.85 13.33%
Week's Top 5 Losers
Symbol 2/11 2/18 % change
ROSG 0.79 0.54 -32.44%
DSCO 2.97 2.16 -27.27%
MNOV 4.58 3.79 -17.25%
MSHL 2.44 2.02 -17.21%
CYTK 1.81 1.52 -16.02% |
